These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15636171)

  • 1. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
    Kaszkin M; Beck KF; Koch E; Erdelmeier C; Kusch S; Pfeilschifter J; Loew D
    Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
    Romiti N; Tramonti G; Corti A; Chieli E
    Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappa B activation.
    Huang TH; Tran VH; Duke RK; Tan S; Chrubasik S; Roufogalis BD; Duke CC
    J Ethnopharmacol; 2006 Mar; 104(1-2):149-55. PubMed ID: 16203115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
    Anauate MC; Torres LM; de Mello SB
    Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
    Abdelouahab N; Heard C
    J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.
    Inaba K; Murata K; Naruto S; Matsuda H
    J Nat Med; 2010 Apr; 64(2):219-22. PubMed ID: 20177800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix.
    Hostanska K; Melzer J; Rostock M; Suter A; Saller R
    J Pharm Pharmacol; 2014 Nov; 66(11):1606-14. PubMed ID: 25175765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of harpagoside in horses after intragastric administration of a Devil's claw (Harpagophytum procumbens) extract.
    Axmann S; Hummel K; Nöbauer K; Razzazi-Fazeli E; Zitterl-Eglseer K
    J Vet Pharmacol Ther; 2019 Jan; 42(1):37-44. PubMed ID: 30242850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harpagoside Content in Devil's Claw Extracts.
    Kondamudi N; Turner MW; McDougal OM
    Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes.
    Haseeb A; Ansari MY; Haqqi TM
    J Orthop Res; 2017 Feb; 35(2):311-320. PubMed ID: 27082319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects Induced by Microwave-Assisted Aqueous Harpagophytum Extract on Rat Cortex Synaptosomes Challenged with Amyloid β-Peptide.
    Ferrante C; Recinella L; Locatelli M; Guglielmi P; Secci D; Leporini L; Chiavaroli A; Leone S; Martinotti S; Brunetti L; Vacca M; Menghini L; Orlando G
    Phytother Res; 2017 Aug; 31(8):1257-1264. PubMed ID: 28635142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targets of the antiinflammatory Harpagophytum procumbens (devil's claw): inhibition of TNFα and COX-2 gene expression by preventing activation of AP-1.
    Fiebich BL; Muñoz E; Rose T; Weiss G; McGregor GP
    Phytother Res; 2012 Jun; 26(6):806-11. PubMed ID: 22072539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Aqueous Extraction and Biological Activity of Harpagophytum procumbens Root on Ex Vivo Rat Colon Inflammatory Model.
    Locatelli M; Ferrante C; Carradori S; Secci D; Leporini L; Chiavaroli A; Leone S; Recinella L; Orlando G; Martinotti S; Brunetti L; Vacca M; Menghini L
    Phytother Res; 2017 Jun; 31(6):937-944. PubMed ID: 28447368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells.
    Datta PK; Lianos EA
    Kidney Int; 1999 Aug; 56(2):486-93. PubMed ID: 10432387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the relative antiinflammatory efficacies of six commercial preparations of Harpagophytum procumbens (Devil's Claw).
    Ouitas NA; Heard C
    Phytother Res; 2010 Mar; 24(3):333-8. PubMed ID: 19610038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ex vivo skin model for the assessment of the potential transcutaneous anti-inflammatory effect of topically applied Harpagophytum procumbens extract.
    Ouitas NA; Heard CM
    Int J Pharm; 2009 Jul; 376(1-2):63-8. PubMed ID: 19383533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by tetranactin of interleukin 1 beta- and cyclic AMP-induced nitric oxide synthase expression in rat renal mesangial cells.
    Kunz D; Walker G; Wiesenberg I; Pfeilschifter J
    Br J Pharmacol; 1996 Aug; 118(7):1621-6. PubMed ID: 8842423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between HPLC and HPTLC-densitometry for the determination of harpagoside from Harpagophytum procumbens CO(2)-extracts.
    Günther M; Schmidt PC
    J Pharm Biomed Anal; 2005 Apr; 37(4):817-21. PubMed ID: 15797807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
    Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
    Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High anti-inflammatory activity of harpagoside-enriched extracts obtained from solvent-modified super- and subcritical carbon dioxide extractions of the roots of Harpagophytum procumbens.
    Günther M; Laufer S; Schmidt PC
    Phytochem Anal; 2006; 17(1):1-7. PubMed ID: 16454469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.